Hydroxyzine Use for Panic Attack with Dyspnea in a 39 kg Child
Hydroxyzine can be safely administered to a 39 kg child experiencing a panic attack with dyspnea in the emergency room setting, with a recommended starting dose of 0.5-1 mg/kg (approximately 20-40 mg). 1
Medication Selection and Dosing
Hydroxyzine is FDA-approved for the symptomatic relief of anxiety and tension associated with psychoneurosis, making it appropriate for panic attacks 1. For pediatric patients:
- Weight-based dosing: 0.5-1 mg/kg per dose
- For a 39 kg child: 20-40 mg would be appropriate
- Route: Oral administration is preferred
- Onset of action: 15-30 minutes for oral administration
Clinical Assessment Before Administration
Before administering hydroxyzine, assess:
- Respiratory status: Ensure dyspnea is due to panic/anxiety rather than a primary respiratory cause
- Cardiovascular status: Check heart rate and blood pressure
- Current medications: Assess for potential drug interactions
- Cardiac history: Hydroxyzine can prolong QT interval 2
Management Algorithm
Rule out organic causes of dyspnea
- Assess vital signs, oxygen saturation, and respiratory effort
- Consider physical signs of respiratory distress versus anxiety-induced dyspnea
First-line interventions for panic-induced dyspnea
Pharmacological intervention
- If non-pharmacological measures are insufficient, proceed with hydroxyzine
- Start with 0.5 mg/kg (approximately 20 mg for a 39 kg child)
- Monitor for response and side effects
Special Considerations
- Sedation: Hydroxyzine may cause sedation, which should be monitored in the emergency setting 4
- Respiratory monitoring: Although hydroxyzine is generally safe, monitor respiratory status as the patient has presented with dyspnea
- QT prolongation: Be cautious in patients with known cardiac conditions 2
- Avoid rapid IV administration: If IV route is necessary (though oral is preferred), administer slowly to prevent potential adverse effects 3
Alternative Approaches
If hydroxyzine is contraindicated or ineffective:
- For severe anxiety with dyspnea: Consider low-dose benzodiazepines (e.g., lorazepam 0.5-1 mg) 3
- For persistent dyspnea: If dyspnea persists and is determined to be primarily anxiety-related, consider consultation with pediatric psychiatry for ongoing management
Monitoring After Administration
- Vital signs every 15-30 minutes
- Observe for sedation and respiratory status
- Monitor for resolution of panic symptoms and dyspnea
- Assess for common side effects: drowsiness, dry mouth, headache
Discharge Considerations
- Ensure complete resolution of symptoms before discharge
- Provide education about panic attacks and breathing techniques
- Consider referral for outpatient mental health follow-up if this is a recurrent issue
Hydroxyzine has demonstrated efficacy for anxiety disorders 4, 5 and is generally well-tolerated in the pediatric population when appropriately dosed. Its antihistamine properties make it a reasonable choice for managing anxiety-induced dyspnea in a child without the risks associated with benzodiazepines.